US647558A
(en)
|
1899-06-15 |
1900-04-17 |
Eugene O Daniels |
Faucet.
|
US3490597A
(en)
|
1966-07-22 |
1970-01-20 |
Purolator Products Inc |
Cover plate for spin-on-filter
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
US4572208A
(en)
|
1983-06-29 |
1986-02-25 |
Utah Medical Products, Inc. |
Metabolic gas monitoring apparatus and method
|
FI78231C
(fi)
|
1984-11-21 |
1989-07-10 |
Instrumentarium Oy |
Maetanordning foer metaboliska storheter anslutbar till en respirator.
|
GB8709871D0
(en)
|
1987-04-27 |
1987-06-03 |
Turner R C |
Peptides
|
US5175145A
(en)
*
|
1988-08-26 |
1992-12-29 |
Amylin Pharmaceuticals, Inc. |
Treatment of diabetes mellitus with amylin agonists
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
US5264372A
(en)
*
|
1991-03-15 |
1993-11-23 |
Amylin Pharmaceuticals, Inc. |
Receptor-based screening methods for amylin agonists and antagonists
|
WO1993010146A1
(en)
|
1991-11-19 |
1993-05-27 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist peptides and uses therefor
|
HU222249B1
(hu)
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
US5580953A
(en)
|
1991-08-14 |
1996-12-03 |
Amylin Pharmaceuticals, Inc. |
Amylin antagonist peptides and uses therefor
|
US5445781A
(en)
|
1991-08-28 |
1995-08-29 |
Centro Sviluppo Settori Impiego S.R.L. |
Process for the injection molding of non-precatalyzed polymerizable resins at high-pressure and flow
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
US5625032A
(en)
|
1993-07-21 |
1997-04-29 |
Amylin Pharmaceuticals, Inc. |
Selective amylin antagonist peptides and uses therefor
|
AU7685894A
(en)
|
1993-09-07 |
1995-03-27 |
Amylin Pharmaceuticals, Inc. |
Methods for regulating gastrointestinal motility
|
US5766627A
(en)
|
1993-11-16 |
1998-06-16 |
Depotech |
Multivescular liposomes with controlled release of encapsulated biologically active substances
|
FR2714057B1
(fr)
*
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
US5596106A
(en)
|
1994-07-15 |
1997-01-21 |
Eli Lilly And Company |
Cannabinoid receptor antagonists
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US5856098A
(en)
|
1994-09-14 |
1999-01-05 |
Progenitor, Inc. |
Detection of a leptin receptor variant
|
BR9509610A
(pt)
|
1994-11-07 |
1997-10-28 |
Pfizer |
Ligandos específicos de neuropeptideo Y1
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
WO1996031526A1
(en)
*
|
1995-04-06 |
1996-10-10 |
Amylin Pharmaceuticals, Inc. |
Anti-obesity agents
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
WO1996040912A1
(en)
|
1995-06-07 |
1996-12-19 |
Amgen Inc. |
Ob protein compositions and method
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
ES2216055T3
(es)
|
1995-08-17 |
2004-10-16 |
Amgen Inc |
Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.
|
WO1997018833A1
(en)
|
1995-11-22 |
1997-05-29 |
Amgen Inc. |
Methods of increasing lean tissue mass using ob protein compositions
|
US6936439B2
(en)
|
1995-11-22 |
2005-08-30 |
Amgen Inc. |
OB fusion protein compositions and methods
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
WO1997020823A2
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
2-amino quinazoline derivatives as npy receptor antagonists
|
AU7692896A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Quinazolin-2,4-diazirines as NPY receptor antagonist
|
WO1997020821A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl derivatives
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
WO1997019682A1
(en)
|
1995-12-01 |
1997-06-05 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
KR19990082330A
(ko)
|
1996-02-06 |
1999-11-25 |
미즈노 마사루 |
신규 화합물 및 이의 의약 용도
|
US6013009A
(en)
|
1996-03-12 |
2000-01-11 |
Karkanen; Kip Michael |
Walking/running heart rate monitoring system
|
AU2670897A
(en)
|
1996-04-04 |
1997-10-29 |
Amgen, Inc. |
Fibulin pharmaceutical compositions and related methods
|
US6007998A
(en)
|
1996-04-22 |
1999-12-28 |
Merck & Co., Inc. |
Leptin assay
|
US20020160935A1
(en)
|
2000-03-24 |
2002-10-31 |
Smithkline Beecham Plc |
Use of leptin antagonists for the treatment of diabetes
|
US20020037553A1
(en)
|
1996-06-06 |
2002-03-28 |
Al-Barazanji Kamal A. |
Fragments of leptin (ob protein)
|
US5874535A
(en)
|
1996-08-01 |
1999-02-23 |
Incyte Pharmaceuticals, Inc. |
Human leptin receptor gene-related protein
|
JP2001501593A
(ja)
|
1996-08-08 |
2001-02-06 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
胃腸運動を調節するための方法
|
US6956026B2
(en)
*
|
1997-01-07 |
2005-10-18 |
Amylin Pharmaceuticals, Inc. |
Use of exendins for the reduction of food intake
|
CA2263826A1
(en)
|
1996-08-30 |
1998-03-05 |
Amgen Inc. |
Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
|
US6458924B2
(en)
*
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
BR9711513A
(pt)
|
1996-09-20 |
1999-08-24 |
Hoechst Ag |
Uso de antagonistas de leptina para o tratamento de resistencia a insulina em diabete do tipo ii
|
IT1288388B1
(it)
†
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
CA2274594C
(en)
*
|
1996-12-16 |
2006-10-10 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazole derivatives
|
CA2275183A1
(en)
|
1996-12-20 |
1998-07-02 |
Amgen Inc. |
Ob fusion protein compositions and methods
|
US6410511B2
(en)
|
1997-01-08 |
2002-06-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
EP0971588B1
(en)
|
1997-01-21 |
2004-03-17 |
Smithkline Beecham Corporation |
Novel cannabinoid receptor modulators
|
FR2758723B1
(fr)
|
1997-01-28 |
1999-04-23 |
Sanofi Sa |
Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
|
CN1982290A
(zh)
|
1997-02-04 |
2007-06-20 |
阿肯色大学评议会 |
杀菌的羧酰胺
|
DK0966436T3
(da)
*
|
1997-02-21 |
2003-03-31 |
Bayer Ag |
Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
|
US6309360B1
(en)
|
1997-03-17 |
2001-10-30 |
James R. Mault |
Respiratory calorimeter
|
WO1998041519A1
(en)
|
1997-03-18 |
1998-09-24 |
Smithkline Beecham Corporation |
Novel cannabinoid receptor agonists
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
CA2288122C
(en)
|
1997-04-23 |
2006-09-26 |
Banyu Pharmaceutical Co., Ltd. |
Neuropeptide y receptor antagonist
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
US7910548B2
(en)
†
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
KR20010021696A
(ko)
|
1997-07-11 |
2001-03-15 |
미즈노 마사루 |
퀴놀린 화합물 및 그의 의약용도
|
BR9811866A
(pt)
|
1997-08-08 |
2000-08-15 |
Amylin Pharmaceuticals Inc |
Compostos agonistas de exendina
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
US7223725B1
(en)
|
1997-11-14 |
2007-05-29 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
NZ504258A
(en)
|
1997-11-14 |
2002-12-20 |
Amylin Pharmaceuticals Inc |
Exendin 3 and 4 agonist compounds for the treatment of diabetes
|
US7220721B1
(en)
|
1997-11-14 |
2007-05-22 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist peptides
|
DK1032587T4
(da)
|
1997-11-14 |
2013-04-08 |
Amylin Pharmaceuticals Llc |
Hidtil ukendte exendinagonist-forbindelser
|
US6680291B1
(en)
|
1998-02-27 |
2004-01-20 |
Regeneron Pharmaceuticals, Inc. |
Modified ciliary neurotrophic factor, method of making and methods of use thereof
|
AU3464599A
(en)
|
1998-04-02 |
1999-10-25 |
Neurogen Corporation |
Aminoalkyl substituted 9h-pyridino(2,3-b)indole and 9h-pyrimidino(4,5-b)indole derivatives
|
JP2004503462A
(ja)
|
1998-04-29 |
2004-02-05 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
肥満症及び他の障害の処置において有用な神経ペプチドyy5レセプターのためのリガンドとしてのn−置換アミノテトラリン
|
US6538194B1
(en)
|
1998-05-29 |
2003-03-25 |
Catalysts & Chemicals Industries Co., Ltd. |
Photoelectric cell and process for producing metal oxide semiconductor film for use in photoelectric cell
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
US6777388B1
(en)
|
1998-08-21 |
2004-08-17 |
Clf Medical Technology Acceleration Program, Inc. |
Leptin-related peptides
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
EP1118001A1
(en)
|
1998-10-02 |
2001-07-25 |
Amgen Inc. |
Method to determine a predisposition to leptin treatment
|
DK1121111T3
(da)
|
1998-10-15 |
2010-05-31 |
Imp Innovations Ltd |
Forbindelser til behandling af vægttab
|
WO2000025806A1
(en)
†
|
1998-11-04 |
2000-05-11 |
Aronne Louis J |
Method for weight control
|
DE69929235T2
(de)
|
1998-11-10 |
2006-08-24 |
Merck & Co., Inc. |
Spiro-indole als y5-rezeptor antagonisten
|
US20020061869A1
(en)
*
|
1998-11-24 |
2002-05-23 |
Lichten Edward M. |
Free insulin testosterone test
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
US6194006B1
(en)
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
US6313295B1
(en)
|
1999-02-16 |
2001-11-06 |
Basf Aktiengesellschaft |
Process for the preparation of 6-(perfluoroalkyl) uracil compounds from carbamate compounds
|
EP1178789B1
(en)
|
1999-03-19 |
2008-07-16 |
Abbott GmbH & Co. KG |
Method of treating eating disorders
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
DK1183245T3
(da)
|
1999-04-22 |
2007-09-24 |
Lundbeck & Co As H |
Selektive NPY(Y5)-antagonister
|
US6124331A
(en)
|
1999-06-30 |
2000-09-26 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (tricyclics)
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
JP2002544127A
(ja)
*
|
1999-04-30 |
2002-12-24 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
修飾されたエキセンジンおよびエキセンジン・アゴニスト
|
MXPA01011321A
(es)
|
1999-05-05 |
2003-08-01 |
Johnson & Johnson |
Neuropeptidos y ligandos de receptores 3a, 4, 5, 9b-tetrahidro-1h-benz(e)indol-2-il amino derivados utiles en el tratamiento de obesidad y otros trastornos.
|
DE60023128T2
(de)
|
1999-05-12 |
2006-07-06 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyrazolcarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
|
US6162260A
(en)
|
1999-05-24 |
2000-12-19 |
Novo Nordisk Biochem North America, Inc. |
Single-bath biopreparation and dyeing of textiles
|
TW514510B
(en)
|
1999-06-11 |
2002-12-21 |
Tanita Seisakusho Kk |
Method and apparatus for measuring distribution of body fat
|
US6214853B1
(en)
*
|
1999-06-30 |
2001-04-10 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
CA2380866A1
(en)
|
1999-06-30 |
2001-01-11 |
Synaptic Pharmaceutical Corporation |
Selective npy (y5) antagonists
|
WO2001007409A1
(en)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
US6380224B1
(en)
|
1999-07-28 |
2002-04-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
|
US6468222B1
(en)
|
1999-08-02 |
2002-10-22 |
Healthetech, Inc. |
Metabolic calorimeter employing respiratory gas analysis
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
EP1227134B1
(en)
|
1999-08-31 |
2006-10-04 |
Daikin Industries, Ltd. |
Polymer composition crosslinkable with ultraviolet
|
CZ20021089A3
(cs)
|
1999-09-30 |
2002-11-13 |
Neurogen Corporation |
Aminosustituované pyrazolo[1,5-a]-1,5-pyrimidiny a pyrazolo[1,5-a]-1,3,5-triaziny
|
EA200200424A1
(ru)
|
1999-09-30 |
2002-12-26 |
Ньюроджен Корпорейшн |
Некоторые гетероциклы, замещенные алкилендиамином
|
HUP0202678A3
(en)
|
1999-09-30 |
2004-06-28 |
Pfizer |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines, pharmaceutical compositions containing them and their use
|
US6530886B1
(en)
|
1999-10-08 |
2003-03-11 |
Tanita Corporation |
Method and apparatus for measuring subcutaneous fat using ultrasonic wave
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
US7563775B2
(en)
*
|
2000-11-01 |
2009-07-21 |
Betty C. Villafuerte |
Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes
|
US6444687B1
(en)
|
1999-12-16 |
2002-09-03 |
Schering Corporation |
Substituted imidazole neuropeptide Y Y5 receptor antagonists
|
JP2004502642A
(ja)
|
2000-02-11 |
2004-01-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
AU2001234128B2
(en)
|
2000-02-22 |
2004-11-11 |
Banyu Pharmaceutical Co., Ltd. |
Novel imidazoline compounds
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
US6703392B2
(en)
|
2000-03-14 |
2004-03-09 |
Actelion Pharmaceuticals Ltd. |
1,2,3,4-tetrahydroisoquinoline derivatives
|
US6602997B2
(en)
|
2000-04-27 |
2003-08-05 |
Shin-Etsu Bio, Inc. |
Whole cell and cell-debris polysaccharide
|
WO2001082925A1
(fr)
|
2000-04-28 |
2001-11-08 |
Takeda Chemical Industries, Ltd. |
Antagonistes de l'hormone concentrant la melanine
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
AU2001263021A1
(en)
|
2000-05-10 |
2001-11-20 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
US7229986B2
(en)
*
|
2000-05-16 |
2007-06-12 |
Takeda Pharmaceutical Company Ltd. |
Melanin-concentrating hormone antagonist
|
AU2001259056A1
(en)
|
2000-05-17 |
2001-11-26 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
TW515705B
(en)
|
2000-05-31 |
2003-01-01 |
Yamato Scale Co Ltd |
Visceral fat meter
|
JP4611608B2
(ja)
|
2000-06-16 |
2011-01-12 |
スミスクライン ビーチャム ピー エル シー |
オレキシン受容体アンタゴニストとして使用するためのピペリジン
|
US7563774B2
(en)
†
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
AU783403B2
(en)
|
2000-07-05 |
2005-10-20 |
H. Lundbeck A/S |
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
|
JP2004516239A
(ja)
|
2000-07-06 |
2004-06-03 |
ニューロジェン コーポレイション |
メラニン凝集ホルモン受容体リガンド
|
US6680203B2
(en)
*
|
2000-07-10 |
2004-01-20 |
Esperion Therapeutics, Inc. |
Fourier transform mass spectrometry of complex biological samples
|
AU2001271066A1
(en)
|
2000-07-17 |
2002-01-30 |
Chugai Seiyaku Kabushiki Kaisha |
Method for screening ligand having biological activity
|
AU2001283938A1
(en)
|
2000-07-24 |
2002-02-05 |
Ardana Bioscience Limited |
Ghrelin antagonists
|
AU2001283955B2
(en)
|
2000-07-31 |
2006-05-18 |
F. Hoffmann-La Roche Ag |
Piperazine derivatives
|
US6296842B1
(en)
|
2000-08-10 |
2001-10-02 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
EP1320364A1
(en)
|
2000-08-21 |
2003-06-25 |
Gliatech, Inc. |
The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
|
JP2004509108A
(ja)
|
2000-09-14 |
2004-03-25 |
シェーリング コーポレイション |
置換尿素神経ペプチドyy5受容体アンタゴニスト
|
CN100334076C
(zh)
|
2000-10-16 |
2007-08-29 |
霍夫曼-拉罗奇有限公司 |
二氢吲哚衍生物及其作为5-ht2受体配体的用途
|
US6475158B1
(en)
|
2000-10-24 |
2002-11-05 |
Korr Medical Technologies, Inc. |
Calorimetry systems and methods
|
BR0115055A
(pt)
*
|
2000-10-30 |
2003-12-30 |
Ortho Mcneil Pharm Inc |
Terapia de combinação compreendendo agentes anticonvulsantes e antidiabéticos
|
AU2002227170A1
(en)
|
2000-11-03 |
2002-05-15 |
Wyeth |
Cycloalkyl(b)(1,4)diazepino(6,7,1-hi)indoles and derivatives
|
US6689385B2
(en)
*
|
2000-11-03 |
2004-02-10 |
Chronorx Llc |
Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
|
PL360982A1
(en)
|
2000-11-20 |
2004-09-20 |
Biovitrum Ab |
Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
|
NZ525700A
(en)
|
2000-11-20 |
2004-12-24 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
|
MXPA03004245A
(es)
|
2000-12-12 |
2003-09-22 |
Neurogen Corp |
Espiro[isobenzofuran-1,4'piperidin]-3-onas y 3h-espiroisobenzofuran-1,4'-piperidinas.
|
BR0116206A
(pt)
|
2000-12-14 |
2003-12-23 |
Amylin Pharmaceuticals Inc |
Peptìdeo yy e agonistas de peptìdeo yy para tratamento de distúrbios metabólicos
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
IL156157A0
(en)
|
2000-12-21 |
2003-12-23 |
Schering Corp |
Heteroaryl urea neuropeptide y y5 receptor antagonists
|
ES2243588T3
(es)
|
2000-12-22 |
2005-12-01 |
Schering Corporation |
Antagonistas piperidinicos de la mch y su uso en el tratamientyo de la obesidad.
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
CA2432085C
(en)
|
2000-12-27 |
2009-02-24 |
F. Hoffmann-La Roche Ag |
Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
|
CN1491232A
(zh)
|
2001-02-06 |
2004-04-21 |
Ĭ��ר������˾ |
免疫原性减弱的经修饰肥胖蛋白
|
EP1385506B1
(en)
|
2001-02-28 |
2009-05-06 |
Merck & Co., Inc. |
Acylated piperidine derivates as melanocortin-4 receptor agonists
|
DE60219295T2
(de)
|
2001-02-28 |
2008-01-03 |
Merck & Co., Inc. |
Acylierte piperidinderivate als melanocortin-4-rezeptoragonisten
|
WO2002068387A2
(en)
|
2001-02-28 |
2002-09-06 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
GB0105069D0
(en)
*
|
2001-03-01 |
2001-04-18 |
Univ Ulster The |
Modified peptide
|
RU2281941C2
(ru)
|
2001-03-22 |
2006-08-20 |
Солвей Фармасьютикалс Б.В. |
Производные 4,5-дигидро-1h-пиразола, обладающие cb1-антагонистической активностью
|
US6825198B2
(en)
*
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
JP4336196B2
(ja)
|
2001-07-18 |
2009-09-30 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作動薬としての架橋ピペリジン誘導体
|
EP1434994A2
(en)
|
2001-09-13 |
2004-07-07 |
Axela Biosensors Inc. |
Method and apparatus for assay based on light diffraction
|
WO2003031410A1
(en)
|
2001-10-09 |
2003-04-17 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
PL214862B1
(pl)
|
2001-10-22 |
2013-09-30 |
Amgen |
Sposób in vitro do okreslania predyspozycji pacjenta ludzkiego z lipoatrofia do reagowania na leczenie bialkiem leptyny, kompozycje farmaceutyczne do zastosowania do leczenia lipoatrofii i kompozycje farmaceutyczne zawierajace bialko leptyny
|
ES2275918T3
(es)
|
2001-11-08 |
2007-06-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Derivados del 1,2,4-tiazol novedosos como moduladores de los receptores de la melanocortina.
|
WO2003045920A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
4-aminoquinoline compounds
|
WO2003045313A2
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co. Inc. |
2-aminoquinoline compounds
|
AR037621A1
(es)
*
|
2001-12-04 |
2004-11-17 |
Schering Corp |
Antagonistas de la hormona concentradora de melanina (mch), composiciones farmaceuticas, un proceso para elaborar una composicion farmaceutica y el uso de dichos compuestos, solos o en combinacion para la fabricacion de un medicamento para el tratamiento de la obesidad
|
JP4733922B2
(ja)
*
|
2002-01-10 |
2011-07-27 |
インペリアル・イノベ−ションズ・リミテッド |
摂食行動の修正
|
US20030207814A1
(en)
|
2002-02-04 |
2003-11-06 |
Chiron Corporation |
Novel guanidinyl derivatives
|
WO2003068738A1
(en)
|
2002-02-11 |
2003-08-21 |
Neurocrine Biosciences, Inc. |
Pyrrole derivatives as ligands of melanocortin receptors
|
EP1494704A1
(en)
*
|
2002-04-04 |
2005-01-12 |
Novo Nordisk A/S |
Glp-1 agonist and cardiovascular complications
|
CA2484968A1
(en)
|
2002-05-10 |
2003-11-20 |
Neurocrine Biosciences, Inc. |
Substituted piperazine as melanocortin receptors ligands
|
US20050288213A1
(en)
*
|
2002-07-18 |
2005-12-29 |
Macneil Douglas J |
Combination therapy for the treatment of obesity
|
US7141561B2
(en)
*
|
2002-07-25 |
2006-11-28 |
Sanofi-Aventis Deutschland Gmbh |
Substituted diaryl heterocycles, process for their preparation and their use as medicaments
|
US6814626B2
(en)
|
2002-10-21 |
2004-11-09 |
L & K Precision Industry Co., Ltd. |
Electrical connector for chargeable battery
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
US20040122033A1
(en)
*
|
2002-12-10 |
2004-06-24 |
Nargund Ravi P. |
Combination therapy for the treatment of obesity
|
US20040209803A1
(en)
|
2002-12-19 |
2004-10-21 |
Alain Baron |
Compositions for the treatment and prevention of nephropathy
|
US7109339B2
(en)
*
|
2002-12-19 |
2006-09-19 |
Bristol-Myers Squibb Company |
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
|
US7268133B2
(en)
*
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
US7145012B2
(en)
*
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
US20050069987A1
(en)
*
|
2003-09-30 |
2005-03-31 |
Daly Thomas J. |
Modified ciliary neurotrophic factor polypeptides with reduced antigenicity
|
US20070149451A1
(en)
*
|
2003-11-17 |
2007-06-28 |
Holmes David G |
Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
|
BRPI0417820A
(pt)
*
|
2003-12-19 |
2007-03-27 |
Bristol Myers Squibb Co |
heterociclos azabicìclicos como moduladores de receptor canabinóide
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
JP5638177B2
(ja)
|
2004-02-11 |
2014-12-10 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
膵臓ポリペプチドファミリーモチーフおよびそのモチーフを含むポリペプチド
|
ATE471340T1
(de)
|
2004-02-11 |
2010-07-15 |
Amylin Pharmaceuticals Inc |
Peptide der amylin familie, verfahren zu deren herstellung und verwendung
|
US7399744B2
(en)
*
|
2004-03-04 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition
|
WO2006032042A2
(en)
*
|
2004-09-15 |
2006-03-23 |
Regeneron Pharmaceuticals, Inc. |
Us of cntf or a cntf derivative in combination with a further compound for the preparation of medicament for the treatment of obesity
|
JP6226510B2
(ja)
|
2012-01-27 |
2017-11-08 |
キヤノン株式会社 |
画像処理システム、処理方法及びプログラム
|
ITMI20130325A1
(it)
|
2013-03-05 |
2014-09-06 |
Telecom Italia Spa |
Metodo per misurare e monitorare il livello di accesso a dati personali generati da risorse di un dispositivo d'utente
|
US9816387B2
(en)
|
2014-09-09 |
2017-11-14 |
United Technologies Corporation |
Attachment faces for clamped turbine stator of a gas turbine engine
|
US9714199B2
(en)
|
2015-09-17 |
2017-07-25 |
I P Creations Limited |
Concealed amalgamated explosive neutralizer and method of manufacture
|